Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|10300||ETCTN||BLockade of PD-1 Added to Standard Therapy to target Measurable Residual Disease in Acute Myeloid Leukemia 1 (BLAST MRD AML-1): A Randomized Phase 2 Study of the Anti-PD-1 Antibody Pembrolizumab in Combination with Conventional Intensive Chemotherapy as Frontline Therapy in Patients with Acute Myeloid Leukemia||Adult CIRB - Early Phase Emphasis||Available to Open|
|AAML0121||COG||"A Phase II Study of Amifostine In Children with Myelodysplastic Syndrome: A Group-wide Study"||Pediatric CIRB||Completed|
|EA1181||ECOG-ACRIN||(CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response||Adult CIRB - Late Phase Emphasis||Available to Open|
|NHSR10.2021||NCI||21st Century Cures Act and PRA Implementation||Adult CIRB - Late Phase Emphasis||Completed|
|PED-CITN-01||Pediatric CITN||3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers||Pediatric CIRB||Available to Open|
|CALGB-49808||CALGB||A 2 X 2 X 2 Factorial Randomized Phase III Trial of Multimodality Therapy Comparing 4 Cycles of Doxorubicin and Cyclophosphamide with or without Dexrazoxane (AC +/- Z) Followed by 12 Weeks of Weekly Paclitaxel with or without Trastuzumab (T H) Followed by Local Therapy Followed by 40 Weeks of Weekly Trastuzumab or none in Women with HER-2+ STAGE IIIA; IIIB or Regional Stage IV Breast Cancer **ADMINISTRATIVELY COMPLETED as of December 15; 2002**||Adult CIRB - Late Phase Emphasis||Completed|
|S1400||SWOG||A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)||Adult CIRB - Late Phase Emphasis||Available to Open|
|NRG-LU003||NRG||A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients: The NCI-NRG ALK Protocol||Adult CIRB - Late Phase Emphasis||Available to Open|
|AOST06B1||COG||A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens||Pediatric CIRB||Available to Open|
|AALL05B1||COG||A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens||Pediatric CIRB||Completed|